Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
South Asian
41%
Diabetes
39%
Type 2 Diabetic Patients
32%
Bariatric Surgery
26%
Hemoglobin A1c (HbA1c)
19%
Patients with Diabetes
19%
Type 1 Diabetes Mellitus (T1DM)
17%
White European
17%
Hypoglycemia
14%
Older Adults
14%
Diabetes Management
13%
Body Mass Index
13%
Inhaled Insulin
13%
South Asian Population
13%
Obesity
12%
Chronic Kidney Disease
12%
Cardiovascular Risk
11%
Type I Diabetes
11%
Glycemic Control
11%
Cholesterol
11%
Insulin
10%
Asian Diabetes
10%
Insulin Therapy
9%
Meta-analysis
9%
United Kingdom
9%
Cardiovascular Disease
9%
Weight Loss
8%
Nephropathy
8%
Frailty
8%
Vascular Complications
8%
Diabetic Ketoacidosis
8%
Telomere Length
8%
Risk Factors
8%
Semaglutide
8%
Care Homes
8%
Canagliflozin
8%
Clinical Evaluation
8%
Diabetic Kidney Disease
7%
Exubera
7%
Cardiovascular Outcomes
7%
Glucose Level
7%
Placebo
7%
Irisin
7%
In Care
6%
Coronavirus Disease (COVID)
6%
Triglycerides
6%
Insulin Resistance
6%
Blood Glucose
6%
Cardiovascular Mortality
6%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
68%
Diabetes
64%
Bariatric Surgery
27%
Patient with Type 2 Diabetes
20%
Cardiovascular Disease
17%
Cardiovascular System
16%
Recombinant Human Insulin
14%
Cardiovascular Risk
12%
Prevalence
11%
Hemoglobin A1c
11%
Insulin Treatment
11%
Chronic Kidney Disease
10%
Body Mass Index
10%
Frailty
10%
Weight Management
10%
Patient with Diabetes
10%
Insulin Dependent Diabetes Mellitus
10%
Hypoglycemia
10%
Nephropathy
9%
Microvascular Complication
8%
Glycemic
8%
Diseases
8%
Triacylglycerol
8%
Glycemic Control
8%
COVID-19
8%
Meta-Analysis
8%
Canagliflozin
8%
Cohort Analysis
7%
Quality of Life
7%
Clinical Trial
7%
Randomized Controlled Trial
7%
Primary Health Care
7%
Diabetes Mellitus
6%
Retrospective Cohort Study
6%
Diabetic Nephropathy
6%
Human Insulin
6%
Hazard Ratio
6%
Impaired Glucose Tolerance
5%
Comorbidity
5%
Glomerular Filtration Rate
5%
Systematic Review
5%
Blood Pressure
5%
Light Chain
5%
Lung
5%
Geriatrics
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Patient with Obesity
5%
End Stage Renal Disease
5%